Grain Fibre and Gut Health
FIBREFECTS
Grain Fibre Modification for Gut-mediated Health Effects
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Wholegrain fibre is known to affect on the gut health, but also may cause intestinal discomfort. Thus, many individuals may avoid the consumption of whole grain cereals in spite of their known health benefits, and may in this regard consume more restricted diets. In the preset study the aim was to technologically modify the cereal fibres to improve its usability and to maintain its health beneficial properties. The objective was to investigate intestinal fermentation of grain dietary fibre and associated effects on gut-mediated metabolic health, such as immunological health and adipose tissue function. The hypothesis was that whole grain products maintain their original beneficial health effects and may be better tolerable when the bran is technologically modified. Additionally, it was hypothesized that gut-mediated bioavailability of plant cell wall compounds and their metabolites affect the metabolic health through their immunomodulatory effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
May 14, 2018
CompletedFirst Posted
Study publicly available on registry
June 8, 2018
CompletedJune 20, 2018
June 1, 2018
2 years
May 14, 2018
June 18, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
gastrointestinal symptoms
intestinal discomfort measured by questionnaire
4 week dietary period
Secondary Outcomes (8)
Glucose concentration
4 week dietary period
Insulin concentration
4 week dietary period
fecal microbiota
4 week dietary period
Exhaled air
4 week dietary period
highly sensitive C-reactive protein
4 week dietary period
- +3 more secondary outcomes
Study Arms (3)
Rye bran bread intervention
EXPERIMENTAL4 week rye bran bread diet intervention with dietary fibre intake of 30g
Rye bread intervention
EXPERIMENTAL4 week rye bread diet intervention with dietary fibre intake of 30g
Wheat bread intervention
ACTIVE COMPARATOR4 week wheat bread diet intervention with dietary fibre intake of 5-20g prior to two other arms
Interventions
4 week dietary intervention rich in rye bran bread
4 week dietary intervention rich in wheat bread as an active comparator for previous two interventions
Eligibility Criteria
You may qualify if:
- BMI 23-30 kg/m2
- abdominally obese (waist circumference \>90 cm (men)/ \>80 cm (women))
- gastrointestinal symptoms
You may not qualify if:
- celiac diseases
- extended allergies
- exceptional diets
- IBD patients
- recent (2 mo) use of antibiotic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Lappi J, Mykkanen H, Bach Knudsen KE, Kirjavainen P, Katina K, Pihlajamaki J, Poutanen K, Kolehmainen M. Postprandial glucose metabolism and SCFA after consuming wholegrain rye bread and wheat bread enriched with bioprocessed rye bran in individuals with mild gastrointestinal symptoms. Nutr J. 2014 Nov 4;13:104. doi: 10.1186/1475-2891-13-104.
PMID: 25370913RESULTLappi J, Aura AM, Katina K, Nordlund E, Kolehmainen M, Mykkanen H, Poutanen K. Comparison of postprandial phenolic acid excretions and glucose responses after ingestion of breads with bioprocessed or native rye bran. Food Funct. 2013 Jun;4(6):972-81. doi: 10.1039/c3fo60078e. Epub 2013 May 14.
PMID: 23674066RESULTRaninen K, Lappi J, Kolehmainen M, Kolehmainen M, Mykkanen H, Poutanen K, Raatikainen O. Diet-derived changes by sourdough-fermented rye bread in exhaled breath aspiration ion mobility spectrometry profiles in individuals with mild gastrointestinal symptoms. Int J Food Sci Nutr. 2017 Dec;68(8):987-996. doi: 10.1080/09637486.2017.1312296. Epub 2017 Apr 9.
PMID: 28391735RESULTKeski-Rahkonen P, Kolehmainen M, Lappi J, Micard V, Jokkala J, Rosa-Sibakov N, Pihlajamaki J, Kirjavainen PV, Mykkanen H, Poutanen K, Gunter MJ, Scalbert A, Hanhineva K. Decreased plasma serotonin and other metabolite changes in healthy adults after consumption of wholegrain rye: an untargeted metabolomics study. Am J Clin Nutr. 2019 Jun 1;109(6):1630-1639. doi: 10.1093/ajcn/nqy394.
PMID: 31136658DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marjukka Kolehmainen, Professor
University of Eastern Finland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2018
First Posted
June 8, 2018
Study Start
January 1, 2011
Primary Completion
December 31, 2012
Study Completion
December 31, 2017
Last Updated
June 20, 2018
Record last verified: 2018-06